Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157


Pathologist Characteristics Associated with Accuracy and Reproducibility of Melanocytic Skin Lesion Interpretation.

Elder DE, Piepkorn M, Barnhill RL, Longton GM, Nelson HD, Knezevich SR, Pepe MS, Carney PA, Titus LJ, Onega T, Tosteson ANA, Weinstock MA, Elmore JG.

J Am Acad Dermatol. 2018 Mar 7. pii: S0190-9622(18)30357-8. doi: 10.1016/j.jaad.2018.02.070. [Epub ahead of print]


Preoperative breast MRI and mortality in older women with breast cancer.

Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA.

Breast Cancer Res Treat. 2018 Mar 7. doi: 10.1007/s10549-018-4732-z. [Epub ahead of print]


Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer.

Chowdhury M, Euhus D, O'Donnell M, Onega T, Choudhary PK, Biswas S.

Breast Cancer Res Treat. 2018 Mar 6. doi: 10.1007/s10549-018-4736-8. [Epub ahead of print]


Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Feb 12. doi: 10.1001/jamainternmed.2017.8642. [Epub ahead of print]


Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.

Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Feb 12. doi: 10.1001/jamainternmed.2017.8549. [Epub ahead of print]


Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment.

Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B.

Acad Radiol. 2018 Feb 9. pii: S1076-6332(18)30010-2. doi: 10.1016/j.acra.2017.12.028. [Epub ahead of print]


Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI.

J Womens Health (Larchmt). 2018 Jan 17. doi: 10.1089/jwh.2017.6623. [Epub ahead of print]


Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer.

Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T.

J Womens Health (Larchmt). 2018 Jan 15. doi: 10.1089/jwh.2017.6428. [Epub ahead of print]


Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.

Nutter EL, Weiss JE, Marotti JD, Barth RJ Jr, Eliassen MS, Goodrich ME, Petersen CL, Onega T.

Cancer. 2017 Dec 20. doi: 10.1002/cncr.31202. [Epub ahead of print]


Utilization of breast cancer screening with magnetic resonance imaging in community practice.

Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T.

J Gen Intern Med. 2018 Mar;33(3):275-283. doi: 10.1007/s11606-017-4224-6. Epub 2017 Dec 6.


Correlation between obesity and fat-infiltrated axillary lymph nodes visualized on mammography.

diFlorio Alexander RM, Haider SJ, MacKenzie T, Goodrich ME, Weiss J, Onega T.

Br J Radiol. 2018 Jan 5:20170110. doi: 10.1259/bjr.20170110. [Epub ahead of print]


An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.

Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA.

Med Care. 2017 Dec;55(12):e81-e87. doi: 10.1097/MLR.0000000000000352.


Disparities in Geographic Accessibility of National Cancer Institute Cancer Centers in the United States.

Xu Y, Fu C, Onega T, Shi X, Wang F.

J Med Syst. 2017 Nov 11;41(12):203. doi: 10.1007/s10916-017-0850-0.


Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R.

J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11.


Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.

Tosteson ANA, Yang Q, Nelson HD, Longton G, Soneji SS, Pepe M, Geller B, Carney PA, Onega T, Allison KH, Elmore JG, Weaver DL.

Breast Cancer Res Treat. 2018 Jan;167(1):195-203. doi: 10.1007/s10549-017-4432-0. Epub 2017 Sep 6.


Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.

Geller BM, Frederick PD, Knezevich SR, Lott JP, Nelson HD, Titus LJ, Carney PA, Tosteson ANA, Onega TL, Barnhill RL, Weinstock MA, Elder DE, Piepkorn MW, Elmore JG.

Dermatol Surg. 2018 Feb;44(2):177-185. doi: 10.1097/DSS.0000000000001256.


Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.

Raffin E, Onega T, Bynum J, Austin A, Carmichael D, Bronner K, Goodney P, Hyams ES.

Cancer Epidemiol. 2017 Oct;50(Pt A):68-75. doi: 10.1016/j.canep.2017.07.015. Epub 2017 Aug 17.


Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS).

Chen Y, Marotti JD, Jenson EG, Onega TL, Johnson KC, Christensen BC.

Exp Mol Pathol. 2017 Aug;103(1):78-83. doi: 10.1016/j.yexmp.2017.07.001. Epub 2017 Jul 12.


Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW.

BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813. Erratum in: BMJ. 2017 Aug 8;358:j3798.


Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters.

Buist DSM, Gao H, Anderson ML, Onega T, Brandzel S, Rabelhofer MA, Bradford SC, Aiello Bowles EJ.

Prev Med. 2017 Sep;102:49-58. doi: 10.1016/j.ypmed.2017.06.028. Epub 2017 Jun 24.


Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD.

Radiology. 2017 Oct;285(1):44-52. doi: 10.1148/radiol.2017162033. Epub 2017 Jun 5.


Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice.

Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas BC, Kerlikowske K.

Acad Radiol. 2017 Oct;24(10):1256-1264. doi: 10.1016/j.acra.2017.03.016. Epub 2017 May 24.


The diagnostic challenge of low-grade ductal carcinoma in situ.

Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA, Carney PA, Geller BM, Longton GM, Nelson HD, Oster NV, Pepe MS, Elmore JG.

Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.


Characteristics associated with requests by pathologists for second opinions on breast biopsies.

Geller BM, Nelson HD, Weaver DL, Frederick PD, Allison KH, Onega T, Carney PA, Tosteson ANA, Elmore JG.

J Clin Pathol. 2017 Nov;70(11):947-953. doi: 10.1136/jclinpath-2016-204231. Epub 2017 May 2.


Population-based geographic access to parent and satellite National Cancer Institute Cancer Center Facilities.

Onega T, Alford-Teaster J, Wang F.

Cancer. 2017 Sep 1;123(17):3305-3311. doi: 10.1002/cncr.30727. Epub 2017 May 2.


A Randomized Study Comparing Digital Imaging to Traditional Glass Slide Microscopy for Breast Biopsy and Cancer Diagnosis.

Elmore JG, Longton GM, Pepe MS, Carney PA, Nelson HD, Allison KH, Geller BM, Onega T, Tosteson AN, Mercan E, Shapiro LG, Brunyé TT, Morgan TR, Weaver DL.

J Pathol Inform. 2017 Mar 10;8:12. doi: 10.4103/2153-3539.201920. eCollection 2017.


Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type.

Clark CR, Tosteson TD, Tosteson ANA, Onega T, Weiss JE, Harris KA, Haas JS.

Cancer Med. 2017 May;6(5):1102-1107. doi: 10.1002/cam4.1036. Epub 2017 Apr 4.


Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.

Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Weinstock MA, Elmore JG, Tosteson ANA.

Br J Dermatol. 2017 Sep;177(3):845-853. doi: 10.1111/bjd.15530. Epub 2017 Jul 9.


National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.


Women's experiences and preferences regarding breast imaging after completing breast cancer treatment.

Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, DeMartini W, Wernli KJ.

Patient Prefer Adherence. 2017 Feb 1;11:199-204. doi: 10.2147/PPA.S122244. eCollection 2017.


Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.

Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson ANA, Onega T.

J Womens Health (Larchmt). 2017 Aug;26(8):820-827. doi: 10.1089/jwh.2016.6076. Epub 2017 Feb 8.


Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns.

Onega T, Haas JS, Bitton A, Brackett C, Weiss J, Goodrich M, Harris K, Pyle S, Tosteson AN.

Am J Manag Care. 2017 Jan;23(1):35-40.


Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients.

Haas JS, Barlow WE, Schapira MM, MacLean CD, Klabunde CN, Sprague BL, Beaber EF, Chen JS, Bitton A, Onega T, Harris K, Tosteson ANA; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium.

J Gen Intern Med. 2017 Apr;32(4):449-457. doi: 10.1007/s11606-016-3973-y. Epub 2017 Jan 9.


National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL.

Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. Epub 2016 Dec 5.


Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?

Jackson SL, Frederick PD, Pepe MS, Nelson HD, Weaver DL, Allison KH, Carney PA, Geller BM, Tosteson AN, Onega T, Elmore JG.

Ann Surg Oncol. 2017 May;24(5):1234-1241. doi: 10.1245/s10434-016-5695-0. Epub 2016 Dec 2.


Medical home transformation and breast cancer screening.

Baughman AW, Brawarsky P, Onega T, Tosteson TD, Wang Q, Tosteson AN, Haas JS.

Am J Manag Care. 2016 Nov 1;22(11):e382-e388.


A model for individualized risk prediction of contralateral breast cancer.

Chowdhury M, Euhus D, Onega T, Biswas S, Choudhary PK.

Breast Cancer Res Treat. 2017 Jan;161(1):153-160. doi: 10.1007/s10549-016-4039-x. Epub 2016 Nov 4.


Radiologist Agreement for Mammographic Recall by Case Difficulty and Finding Type.

Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B.

J Am Coll Radiol. 2016 Nov;13(11S):e72-e79. doi: 10.1016/j.jacr.2016.09.035.


Screening Mammography Use Among Older Women Before and After the 2009 U.S. Preventive Services Task Force Recommendations.

Chang CH, Bynum JP, Onega T, Colla CH, Lurie JD, Tosteson AN.

J Womens Health (Larchmt). 2016 Oct;25(10):1030-1037. Epub 2016 Jul 18.


Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy.

Weiss JE, Goodrich M, Harris KA, Chicoine RE, Synnestvedt MB, Pyle SJ, Chen JS, Herschorn SD, Beaber EF, Haas JS, Tosteson AN, Onega T; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium.

J Am Coll Radiol. 2017 Feb;14(2):198-207.e2. doi: 10.1016/j.jacr.2016.08.017. Epub 2016 Oct 13.


Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.

Lee KC, Peacock S, Weinstock MA, Zhao GA, Knezevich SR, Elder DE, Barnhill RL, Piepkorn MW, Reisch LM, Carney PA, Onega T, Lott JP, Elmore JG.

J Am Acad Dermatol. 2017 Jan;76(1):121-128. doi: 10.1016/j.jaad.2016.07.029. Epub 2016 Sep 28.


Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium.

Beaber EF, Tosteson AN, Haas JS, Onega T, Sprague BL, Weaver DL, McCarthy AM, Doubeni CA, Quinn VP, Skinner CS, Zauber AG, Barlow WE.

Breast Cancer Res Treat. 2016 Nov;160(2):323-331. Epub 2016 Sep 24.


A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care.

Haas JS, Baer HJ, Eibensteiner K, Klinger EV, St Hubert S, Getty G, Brawarsky P, Orav EJ, Onega T, Tosteson AN, Bates DW, Colditz G.

Am J Prev Med. 2017 Jan;52(1):100-105. doi: 10.1016/j.amepre.2016.07.013. Epub 2016 Sep 14.


Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.

Weinstock MA, Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Pearson L, Piepkorn M, Barnhill RL, Elmore JG, Tosteson ANA.

Br J Dermatol. 2017 Apr;176(4):949-954. doi: 10.1111/bjd.15077. Epub 2017 Mar 1.


The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women.

Goodrich ME, Weiss J, Onega T, Balch SL, Buist DS, Kerlikowske K, Henderson LM, Hubbard RA; Breast Cancer Surveillance Consortium.

Breast J. 2016 Nov;22(6):616-622. doi: 10.1111/tbj.12651. Epub 2016 Aug 23.


Radiologists' interpretive skills in screening vs. diagnostic mammography: are they related?

Elmore JG, Cook AJ, Bogart A, Carney PA, Geller BM, Taplin SH, Buist DS, Onega T, Lee CI, Miglioretti DL.

Clin Imaging. 2016 Nov - Dec;40(6):1096-1103. doi: 10.1016/j.clinimag.2016.06.014. Epub 2016 Jul 1.


Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study.

Sprague BL, Conant EF, Onega T, Garcia MP, Beaber EF, Herschorn SD, Lehman CD, Tosteson AN, Lacson R, Schnall MD, Kontos D, Haas JS, Weaver DL, Barlow WE; PROSPR Consortium.

Ann Intern Med. 2016 Oct 4;165(7):457-464. doi: 10.7326/M15-2934. Epub 2016 Jul 19.


Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging.

Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C.

Am J Surg. 2017 Jan;213(1):132-139.e2. doi: 10.1016/j.amjsurg.2016.03.014. Epub 2016 Jun 12.


Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.

Elmore JG, Tosteson AN, Pepe MS, Longton GM, Nelson HD, Geller B, Carney PA, Onega T, Allison KH, Jackson SL, Weaver DL.

BMJ. 2016 Jun 22;353:i3069. doi: 10.1136/bmj.i3069.


Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S.

Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson AN, Wernli KJ, Onega T.

Prev Med. 2016 Aug;89:169-77. doi: 10.1016/j.ypmed.2016.05.034. Epub 2016 May 31.

Supplemental Content

Support Center